Welcome to our dedicated page for Bio-Key Intl news (Ticker: BKYI), a resource for investors and traders seeking the latest updates and insights on Bio-Key Intl stock.
BIO-key International, Inc. (NASDAQ: BKYI) is an identity and access management (IAM) and biometric authentication company whose news flow centers on product innovation, strategic partnerships, investor communications, and capital markets activity. Press releases describe BIO-key as a biometric-centric, multi-factor IAM provider enabling phoneless, tokenless, passwordless, and phishing-resistant authentication for enterprise and large-scale identity deployments.
On this page, readers can follow updates on BIO-key’s participation in industry conferences and investor events, such as the Gartner Identity & Access Management Summit, the Africa Tech Festival, and the DealFlow Discovery investor conference. These announcements often highlight new passwordless capabilities, identity-bound biometric technologies, and demonstrations of the PortalGuard IAM platform.
Company news also covers strategic partnerships that extend BIO-key’s reach in key regions. Recent releases describe collaborations with SAVIS Group in Vietnam, VaporVM in the Middle East and Africa, and Cloud Distribution in Saudi Arabia. Through these relationships, BIO-key’s IAM and biometric solutions are integrated into broader cybersecurity and digital transformation offerings for enterprises, government agencies, and institutions.
Investors can track earnings-related communications and balance sheet updates through quarterly results announcements and associated investor calls. BIO-key’s news includes details on hardware launches such as the EcoID III fingerprint scanner, as well as disclosures about warrant exercise agreements and secured promissory notes that affect the company’s capital structure.
By monitoring the BKYI news feed, users can see how BIO-key positions its biometric and IAM technologies in sectors such as defense, finance, government, and education, and stay informed about material events reported in press releases that complement the company’s formal SEC filings.
BIO-key (NASDAQ:BKYI) will present at the DealFlow Discovery investor conference at the Borgata in Atlantic City on Jan. 28–29, 2026. CEO Mike DePasquale is scheduled to present on Jan. 28 at 11:30am ET in Room 1 and will be available for 1-on-1 investor meetings during the event. Institutional investors, family offices, and high-net-worth investors may register at no cost. Presentation materials will be posted on the DealFlow Discovery website in January and registration is available online.
BIO-key (NASDAQ: BKYI) will present at the DealFlow Discovery investor conference on Jan 28–29, 2026 at the Borgata hotel in Atlantic City, New Jersey.
CEO Mike DePasquale will deliver a presentation and be available for 1-on-1 meetings; presentation details will be posted on the conference website in January. Institutional investors, family offices and high-net-worth investors may register to attend at no cost via the DealFlow Discovery registration page.
BIO-key (NASDAQ: BKYI) will participate in the 2025 Gartner Identity & Access Management Summit: North America, December 8-10 in Grapevine, TX, exhibiting at Booth 236. The company will demonstrate its passwordless, phoneless, tokenless authentication portfolio including identity-bound biometrics, phishing-resistant MFA alternatives, and cost-effective IAM modernization aimed at reducing credential theft, support costs, and friction while supporting Zero Trust adoption.
BIO-key will engage IAM leaders across finance, healthcare, government, education, and manufacturing to discuss deployment use cases and challenges.
BIO-key (NASDAQ: BKYI) announced a strategic partnership with SAVIS Group to localize and deliver BIO-key’s identity and biometric authentication solutions across Vietnam, effective Nov 17, 2025. SAVIS Group will act as an authorized distributor, providing localized pre-sales, deployment, and technical support through its enterprise ecosystem.
Products to be offered include PortalGuard, Passkey:YOU (FIDO2), PIN:You, WEB-key, identity-bound biometrics, and certified scanners PIV-Pro and EcoID III.
BIO-key (Nasdaq: BKYI) reported Q3 2025 results and held an investor call on November 14, 2025.
Key Q3 metrics: revenue $1,548,706 (down from $2,144,804 a year ago), gross margin 77%, and net loss $964,849 (or $0.15 per share). Balance sheet at September 30, 2025 included $2.04M cash and $3.75M total current assets. The company launched the EcoID III (FAP 20) fingerprint scanner, secured a large Middle East defense deployment, shipped $134,000 in follow-on orders, and expects 2025 full-year revenue of $6.5–$7.0M. Subsequent financing included a $3.1M warrant exercise on October 27, 2025 and remaining notes outstanding of $675,000.
BIO-key (NASDAQ: BKYI) announced a strategic partnership with Dubai-headquartered VaporVM on November 12, 2025 to expand distribution of BIO-key’s identity and biometric solutions across the Middle East and Africa. VaporVM will integrate and promote BIO-key’s PortalGuard IAM platform, Passkey:YOU (FIDO2 passwordless), PIN:You, WEB-key biometric engine, identity-bound biometrics, and certified scanners, and provide local deployment, partner enablement, and technical support. The collaboration targets enterprises and public-sector organizations operating on AWS, Azure, and GCP, aiming to combine VaporVM’s regional cloud and managed-services presence with BIO-key’s authentication technology to support secure, compliant digital transformation.
BIO-key (NASDAQ: BKYI) will showcase passwordless and identity-bound biometric authentication at Africa Tech Festival 2025, Nov 10–13 at the Cape Town International Convention Centre (CTICC), Booth H72. BIO-key and partner Altron Arrow will demonstrate Identity-Bound Biometrics (IBB), the PortalGuard® IAM platform, and Passkey:YOU™ for phoneless, tokenless access.
Visitors can meet the team and view live demonstrations aimed at enabling secure, scalable, and inclusive digital identity solutions for governments and enterprises across Africa.
BIO-key International (NASDAQ: BKYI) will host its Q3 investor call on Friday, November 14, 2025 at 10:00 a.m. ET. The company will release third-quarter results before the market opens that morning.
Chairman & CEO Mike DePasquale and CFO Cecilia Welch will lead the call and a Q&A session. A live webcast and replay will be available, and the audio replay access details are provided for U.S. and international listeners.
Dial-in and webcast details will be available to investors; the webcast replay will remain accessible for three months.
BIO-key (NASDAQ: BKYI) announced a significant deployment with a major Middle East defense-sector security organisation on Nov. 7, 2025.
The solution will protect critical infrastructure and sensitive access environments using BIO-key’s biometric and multi-factor authentication, avoiding reliance on mobile devices or hardware tokens. The customer requested anonymity for security reasons. BIO-key said the contract is one of its largest regional security-sector deployments and follows a new strategic partnership with Cloud Distribution to accelerate in-country delivery and opportunities.
BIO-key (NASDAQ: BKYI) entered into a warrant inducement agreement dated Oct 27, 2025, with an existing institutional investor to induce exercise of Series A and Series B warrants originally issued Jan 15, 2025.
The investor agreed to purchase 3,091,668 shares at a reduced exercise price of $1.02 per share, producing gross proceeds of approximately $3.1 million before placement agent fees and offering expenses. Maxim Group is the exclusive placement agent.
As consideration, BIO-key will issue 6,183,336 unregistered new warrants exercisable at $1.02 per share, immediately exercisable and expiring five years from issuance, and will file an SEC registration statement covering resale of shares issuable on exercise.
FAQ
What is the current stock price of Bio-Key Intl (BKYI)?
What is the market cap of Bio-Key Intl (BKYI)?
